- Home
- VRA vs CUE Comparison
VRA vs CUE Comparison
Compare VRA & CUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRA
- CUE
- Stock Information
- Founded
- VRA 1982
- CUE 2014
- Country
- VRA United States
- CUE United States
- Employees
- VRA N/A
- CUE N/A
- Industry
- VRA Apparel
- CUE Biotechnology: Pharmaceutical Preparations
- Sector
- VRA Consumer Discretionary
- CUE Health Care
- Exchange
- VRA Nasdaq
- CUE Nasdaq
- Market Cap
- VRA 60.6M
- CUE 56.1M
- IPO Year
- VRA 2010
- CUE 2018
- Fundamental
- Price
- VRA $2.05
- CUE $0.86
- Analyst Decision
- VRA Buy
- CUE Strong Buy
- Analyst Count
- VRA 3
- CUE 2
- Target Price
- VRA $4.00
- CUE $3.00
- AVG Volume (30 Days)
- VRA 222.4K
- CUE 220.6K
- Earning Date
- VRA 09-11-2025
- CUE 11-13-2025
- Dividend Yield
- VRA N/A
- CUE N/A
- EPS Growth
- VRA N/A
- CUE N/A
- EPS
- VRA N/A
- CUE N/A
- Revenue
- VRA $332,526,000.00
- CUE $8,286,000.00
- Revenue This Year
- VRA N/A
- CUE N/A
- Revenue Next Year
- VRA $2.33
- CUE N/A
- P/E Ratio
- VRA N/A
- CUE N/A
- Revenue Growth
- VRA N/A
- CUE N/A
- 52 Week Low
- VRA $1.71
- CUE $0.54
- 52 Week High
- VRA $5.99
- CUE $1.99
- Technical
- Relative Strength Index (RSI)
- VRA 51.62
- CUE 58.69
- Support Level
- VRA $2.08
- CUE $0.71
- Resistance Level
- VRA $2.23
- CUE $0.73
- Average True Range (ATR)
- VRA 0.10
- CUE 0.04
- MACD
- VRA 0.01
- CUE 0.01
- Stochastic Oscillator
- VRA 53.61
- CUE 95.92
About VRA Vera Bradley Inc.
Vera Bradley Inc designs women's handbags, travel items, and accessories. Each category comprises a substantial component of total sales, with the bags category comprising the majority of the company's sales are made directly to customers through Vera Bradley's retail stores and e-commerce sites. The company also has a substantial wholesale business selling to specialty retail and department stores. Almost all company sales are in the United States. Vera Bradley uses third-party manufacturers in Asia to produce its products, and the company distributes the products through its distribution center in Indiana. The Company has three reportable segments: Vera Bradley Direct, Vera Bradley Indirect, and Pura Vida. The majority of revenue is from the Vera Bradley Direct segment.
About CUE Cue Biopharma Inc.
Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.